Cleared Traditional

K051638 - INVERNESS MEDICAL TESTPACK + PLUS STREP...

K051638 is the FDA 510(k) clearance for INVERNESS MEDICAL TESTPACK + PLUS STREP... by Unipath , Ltd.. It is a Class 1 Microbiology device (product code GTY) cleared through the Traditional 510(k) pathway after a 169-day FDA review.

K051638 · Unipath , Ltd. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
169d
Days
Class 1
Risk

K051638 is an FDA 510(k) clearance for the INVERNESS MEDICAL TESTPACK + PLUS STREP A WITH OBC. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Unipath , Ltd. (Bedford, GB). The FDA issued a Cleared decision on December 6, 2005 after a review of 169 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Unipath , Ltd. devices

Submission Details

510(k) Number K051638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2005
Decision Date December 06, 2005
Days to Decision 169 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 102d · This submission: 169d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 28
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K051638.
SOFIA STREP A FIA
K123793 · Quidel Corporation · Jun 2013
BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF GROUP A STREP
K122718 · Becton, Dickinson and Company · Feb 2013
BIOSTREP A, BIOSIGN STREP A, STATUSFIRST STREP A
K082661 · Princeton BioMeditech Corp. · Oct 2008
STATUS FIRST STREP A
K040708 · Princeton BioMeditech Corp. · Nov 2004
ACON STREP A RAPID TEST DEVICE
K031784 · ACON Laboratories, Inc. · Jul 2003
SAS STREPALERT
K023270 · Sa Scientific, Inc. · Oct 2002